Quotes 5-day view Delayed Otc Markets
2 435 527
1 643 407
1 479 086 Volume
Estimated financial data (e) (USD)
Net income 2023
Net Debt 2023
P/E ratio 2023
Net income 2024
Net Debt 2024
P/E ratio 2024
Capi. / Sales 2023
EV / Sales 2024
Nbr of Employees
Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. The CompanyÔÇÖs segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library...
All news about SORRENTO THERAPEUTICS, INC.
05/15 Sorrento Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March ..
05/14 Sorrento Therapeutics, Inc.'s Bankruptcy Court Orders Brokerage Firms to Credit Dividen..
04/25 Sorrento Therapeutics, Inc.'s Bankruptcy Court Extends the Lockup Period on Shares of S..
04/20 Sorrento Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
04/17 Scilex Holding Company Announces Final Postponement of Annual Meeting of Stockholders
04/10 SORRENTO THERAPEUTICS, INC. Other Events, Financial Statements and Exhibits (form 8-K/..
04/10 Sorrento Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
04/04 Sorrento Therapeutics, Inc.'s Bankruptcy Court Requires Brokerages to Provide Informati..
03/31 Sorrento Therapeutics, Inc. : Entry into a Material Definitive Agreement, Regulation FD Di..
03/29 Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Pos..
03/28 Scilex Holding Company Reports Substantial Underreporting of More Than 44 Million Share..
03/20 Sorrento Therapeutics, Inc. : Other Events, Regulation FD Disclosure, Financial Statements..
03/17 Court Confirms Sorrento Therapeutics, Inc.'s $125 Million Arbitration Award Against Nan..
03/16 SORRENTO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Conditio..
03/16 Sorrento Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
News in other languages on SORRENTO THERAPEUTICS, INC.
Analyst Recommendations on SORRENTO THERAPEUTICS, INC.
ETFs positioned on SORRENTO THERAPEUTICS, INC. ETFs and Trackers with Trackinsight
Chart SORRENTO THERAPEUTICS, INC.
Technical analysis trends SORRENTO THERAPEUTICS, INC.
Short Term Mid-Term Long Term Trends Bullish Bearish Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target